Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
J Mol Biol. 2011 Apr 29;408(2):366-78. doi: 10.1016/j.jmb.2011.02.036. Epub 2011 Feb 25.
A molecular understanding of substrate recognition of protein kinases provides an important basis for the development of substrate competitive inhibitors. Here, we explored substrate recognition and competitive inhibition of glycogen synthase kinase (GSK)-3β using molecular and computational tools. In previous work, we described Gln89 and Asn95 within GSK-3β as important substrates binding sites. Here, we show that the cavity bordered by loop 89-QDKRFKN-95, located in the vicinity of the GSK-3β catalytic core, is a promiscuous substrate binding subsite. Mutations within this segment highlighted Phe93 as an additional essential contact residue for substrates' recognition. However, unlike Gln89 and Asn95, Phe93 was also important for the binding of our previously described substrate competitive inhibitor, L803 [KEAPPAPPQS(p)P], and its cell-permeable variant L803-mts. The effects of the substitution of charged or polar residues within L803 further suggested that binding to GSK-3β is governed by hydrophobic interactions. Our computational model of GSK-3β bound to L803 was in agreement with the experimental data. It revealed L803 binding with a hydrophobic surface patch and identified interactions between Pro8 (L803) and Phe93 (GSK-3β). Computational modeling of new L803 variants predicted that inhibition would be strengthened by adding contacts with Phe93 or by increasing the hydrophobic content of the peptide. Indeed, the newly designed L803 variants showed improved inhibition. Our study identified different and overlapping elements in GSK-3β substrate and inhibitor recognition and provides a novel example for model-based rational design of substrate competitive inhibitors for GSK-3.
一种对蛋白激酶底物识别的分子理解为开发底物竞争性抑制剂提供了重要基础。在这里,我们使用分子和计算工具来探索糖原合成酶激酶(GSK)-3β的底物识别和竞争性抑制。在之前的工作中,我们描述了 GSK-3β 中的 Gln89 和 Asn95 作为重要的底物结合位点。在这里,我们表明,由环 89-QDKRFKN-95 包围的腔,位于 GSK-3β 催化核心附近,是一个混杂的底物结合亚位点。该片段内的突变突出了 Phe93 作为识别底物的另一个必需接触残基。然而,与 Gln89 和 Asn95 不同,Phe93 对我们之前描述的底物竞争性抑制剂 L803 [KEAPPAPPQS(p)P]及其细胞渗透性变体 L803-mts 的结合也很重要。L803 中带电荷或极性残基的取代的影响进一步表明,与 GSK-3β 的结合受疏水性相互作用的控制。我们结合 L803 的 GSK-3β 计算模型与实验数据一致。它揭示了 L803 与疏水面结合,并确定了 Pro8(L803)和 Phe93(GSK-3β)之间的相互作用。对新的 L803 变体的计算建模预测,通过增加与 Phe93 的接触或增加肽的疏水性内容,抑制作用将得到加强。事实上,新设计的 L803 变体显示出更好的抑制作用。我们的研究确定了 GSK-3β 底物和抑制剂识别中的不同和重叠元素,并为基于模型的 GSK-3 底物竞争性抑制剂的合理设计提供了一个新的范例。